Share-based Payment Arrangement, Expense of AtriCure, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
AtriCure, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • AtriCure, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $12,424,000, a 20% increase year-over-year.
  • AtriCure, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $43,810,000, a 11% increase year-over-year.
  • AtriCure, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $40,405,000, a 13% increase from 2023.
  • AtriCure, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $35,728,000, a 24% increase from 2022.
  • AtriCure, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28,771,000, a 2.5% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

AtriCure, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $43,810,000 $12,424,000 +$2,060,000 +20% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $41,750,000 $11,371,000 +$980,000 +9.4% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $40,770,000 $9,630,000 +$365,000 +3.9% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $40,405,000 $10,385,000 +$1,073,000 +12% 01 Oct 2024 31 Dec 2024 10-K 14 Feb 2025 2024 FY
Q3 2024 $39,332,000 $10,364,000 +$1,703,000 +20% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 $37,629,000 $10,391,000 +$1,396,000 +16% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025 2025 Q2
Q1 2024 $36,233,000 $9,265,000 +$505,000 +5.8% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q4 2023 $35,728,000 $9,312,000 +$2,115,000 +29% 01 Oct 2023 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $33,613,000 $8,661,000 +$1,660,000 +24% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024 2024 Q3
Q2 2023 $31,953,000 $8,995,000 +$1,471,000 +20% 01 Apr 2023 30 Jun 2023 10-Q 31 Jul 2024 2024 Q2
Q1 2023 $30,482,000 $8,760,000 +$1,711,000 +24% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $28,771,000 $7,197,000 -$342,000 -4.5% 01 Oct 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
Q3 2022 $29,113,000 $7,001,000 +$207,000 +3% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $28,906,000 $7,524,000 +$383,000 +5.4% 01 Apr 2022 30 Jun 2022 10-Q 26 Jul 2023 2023 Q2
Q1 2022 $28,523,000 $7,049,000 +$445,000 +6.7% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 $28,078,000 $7,539,000 +$1,023,000 +16% 01 Oct 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
Q3 2021 $27,055,000 $6,794,000 +$1,245,000 +22% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $25,810,000 $7,141,000 +$948,000 +15% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $24,862,000 $6,604,000 +$2,220,000 +51% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $22,642,000 $6,516,000 +$1,355,000 +26% 01 Oct 2020 31 Dec 2020 10-K 22 Feb 2023 2022 FY
Q3 2020 $21,287,000 $5,549,000 +$1,262,000 +29% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $20,025,000 $6,193,000 +$1,818,000 +42% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $18,207,000 $4,384,000 +$230,000 +5.5% 01 Jan 2020 31 Mar 2020 10-Q 28 Apr 2021 2021 Q1
Q4 2019 $17,977,000 $5,161,000 +$332,000 +6.9% 01 Oct 2019 31 Dec 2019 10-K 17 Feb 2022 2021 FY
Q3 2019 $17,645,000 $4,287,000 +$45,000 +1.1% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $17,600,000 $4,375,000 +$841,000 +24% 01 Apr 2019 30 Jun 2019 10-Q 29 Jul 2020 2020 Q2
Q1 2019 $16,759,000 $4,154,000 +$264,000 +6.8% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q4 2018 $16,495,000 $4,829,000 +$1,161,000 +32% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q3 2018 $15,334,000 $4,242,000 +$620,000 +17% 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3
Q2 2018 $14,714,000 $3,534,000 -$163,000 -4.4% 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019 2019 Q2
Q1 2018 $14,877,000 $3,890,000 +$262,000 +7.2% 01 Jan 2018 31 Mar 2018 10-Q 26 Apr 2019 2019 Q1
Q4 2017 $14,615,000 $3,668,000 +$767,000 +26% 01 Oct 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
Q3 2017 $13,848,000 $3,622,000 +$695,000 +24% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018 2018 Q3
Q2 2017 $13,153,000 $3,697,000 +$670,000 +22% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $12,483,000 $3,628,000 +$786,000 +28% 01 Jan 2017 31 Mar 2017 10-Q 27 Apr 2018 2018 Q1
Q4 2016 $11,697,000 $2,901,000 +$437,000 +18% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
Q3 2016 $11,260,000 $2,927,000 +$535,000 +22% 01 Jul 2016 30 Sep 2016 10-Q 02 Nov 2017 2017 Q3
Q2 2016 $10,725,000 $3,027,000 +$610,000 +25% 01 Apr 2016 30 Jun 2016 10-Q 28 Jul 2017 2017 Q2
Q1 2016 $10,115,000 $2,842,000 +$1,118,000 +65% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q4 2015 $8,997,000 $2,464,000 +$597,000 +32% 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
Q3 2015 $8,400,000 $2,392,000 +$676,000 +39% 01 Jul 2015 30 Sep 2015 10-Q 28 Oct 2016 2016 Q3
Q2 2015 $7,724,000 $2,417,000 +$571,000 +31% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016 2016 Q2
Q1 2015 $7,153,000 $1,724,000 -$418,000 -20% 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016 2016 Q1
Q4 2014 $7,571,000 $1,867,000 +$859,000 +85% 01 Oct 2014 31 Dec 2014 10-K 08 Mar 2017 2016 FY
Q3 2014 $6,712,000 $1,716,000 +$982,000 +134% 01 Jul 2014 30 Sep 2014 10-Q 30 Oct 2015 2015 Q3
Q2 2014 $5,730,000 $1,846,000 +$1,026,000 +125% 01 Apr 2014 30 Jun 2014 10-Q 31 Jul 2015 2015 Q2
Q1 2014 $4,704,000 $2,142,000 +$1,624,000 +314% 01 Jan 2014 31 Mar 2014 10-Q 01 May 2015 2015 Q1
Q4 2013 $3,080,000 $1,008,000 +$480,000 +91% 01 Oct 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
Q3 2013 $2,600,000 $734,000 -$377,000 -34% 01 Jul 2013 30 Sep 2013 10-Q 31 Oct 2014 2014 Q3
Q2 2013 $2,977,000 $820,000 -$321,000 -28% 01 Apr 2013 30 Jun 2013 10-Q 30 Jul 2014 2014 Q2
Q1 2013 $3,298,000 $518,000 -$170,000 -25% 01 Jan 2013 31 Mar 2013 10-Q 30 Apr 2014 2014 Q1
Q4 2012 $3,468,000 $528,000 01 Oct 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
Q3 2012 $1,111,000 +$395,000 +55% 01 Jul 2012 30 Sep 2012 10-Q 01 Nov 2013 2013 Q3
Q2 2012 $1,141,000 +$411,000 +56% 01 Apr 2012 30 Jun 2012 10-Q 02 Aug 2013 2013 Q2
Q1 2012 $688,000 01 Jan 2012 31 Mar 2012 10-Q 03 May 2013 2013 Q1
Q3 2011 $716,000 01 Jul 2011 30 Sep 2011 10-Q 02 Nov 2012 2012 Q3
Q2 2011 $730,000 01 Apr 2011 30 Jun 2011 10-Q 03 Aug 2012 2012 Q2

AtriCure, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $40,405,000 +$4,677,000 +13% 01 Jan 2024 31 Dec 2024 10-K 14 Feb 2025 2024 FY
2023 $35,728,000 +$6,957,000 +24% 01 Jan 2023 31 Dec 2023 10-K 14 Feb 2025 2024 FY
2022 $28,771,000 +$693,000 +2.5% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
2021 $28,078,000 +$5,436,000 +24% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
2020 $22,642,000 +$4,665,000 +26% 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2023 2022 FY
2019 $17,977,000 +$1,482,000 +9% 01 Jan 2019 31 Dec 2019 10-K 17 Feb 2022 2021 FY
2018 $16,495,000 +$1,880,000 +13% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $14,615,000 +$2,918,000 +25% 01 Jan 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
2016 $11,697,000 +$2,700,000 +30% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $8,997,000 +$1,426,000 +19% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
2014 $7,571,000 +$4,491,000 +146% 01 Jan 2014 31 Dec 2014 10-K 08 Mar 2017 2016 FY
2013 $3,080,000 -$388,000 -11% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $3,468,000 +$537,000 +18% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $2,931,000 +$178,000 +6.5% 01 Jan 2011 31 Dec 2011 10-K 11 Mar 2014 2013 FY
2010 $2,753,000 01 Jan 2010 31 Dec 2010 10-K 08 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.